BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis

NCT00095173 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Rheumatoid Arthritis

Interventions

DRUG: Abatacept
DRUG: Placebo
DRUG: Abatacept

Sponsor

Bristol-Myers Squibb